{"Literature Review": "Gene therapy has emerged as a revolutionary approach in the treatment of genetic disorders and cancer, with significant milestones such as the approval of Luxturna and Zolgensma by the US Food and Drug Administration. Despite these advancements, the efficient and safe delivery of nucleic acids to their target sites remains a formidable challenge. Peptide-based vectors have garnered attention as a promising solution to this problem, owing to their biocompatibility, low immunogenicity, and the ability to be engineered for specific interactions with cells and biomolecules. This literature review explores the role of peptides in gene delivery, focusing on cell-penetrating peptides (CPPs) and intracellular targeting peptides, their mechanisms of action, and strategies to enhance their stability and bioavailability for therapeutic applications. Cell-penetrating peptides, characterized by their ability to traverse cellular membranes, have been extensively studied for their potential in delivering a wide range of therapeutic agents, including nucleic acids. These peptides can be derived from natural sources or designed de novo, offering versatility in their application. For instance, the TAT peptide, derived from the HIV-1 transactivator of transcription protein, has been widely utilized for its efficient cellular uptake capabilities. Similarly, synthetic CPPs, such as the oligoarginine peptides, have demonstrated significant potential in delivering siRNA and mRNA into cells, facilitating gene silencing and expression, respectively. Intracellular targeting peptides represent another class of peptides that can direct therapeutic agents to specific subcellular compartments, enhancing the precision of gene therapy. These peptides can be designed to target organelles such as the nucleus, mitochondria, or lysosomes, thereby improving the therapeutic efficacy of gene delivery systems. For example, nuclear localization signals (NLS) have been employed to enhance the nuclear delivery of plasmid DNA, a critical step in the expression of therapeutic genes. The challenge of endosomal escape is a significant barrier in the intracellular delivery of nucleic acids. Peptides that facilitate endosomal escape, such as the GALA peptide, which undergoes a pH-dependent conformational change to disrupt endosomal membranes, have been developed to address this issue. These peptides enhance the release of nucleic acids into the cytoplasm, increasing the efficiency of gene delivery. To improve the stability and bioavailability of peptide-based vectors, various strategies have been explored. These include the incorporation of non-natural amino acids, cyclization of peptides, and the use of peptide-polymer conjugates. Such modifications can protect peptides from proteolytic degradation and extend their circulation time in vivo, thereby enhancing their therapeutic potential. In conclusion, peptide-based vectors offer a versatile and tunable platform for the delivery of nucleic acids in gene therapy. Through the continued development of CPPs, intracellular targeting peptides, and strategies to enhance peptide stability and bioavailability, peptide-based vectors hold great promise for advancing the field of gene therapy and expanding its applications to a broader range of diseases.", "References": [{"title": "Cell-penetrating peptides: from molecular mechanisms to therapeutics", "authors": "Mae M, Langel U", "journal": "Biochimica et Biophysica Acta (BBA) - Biomembranes", "year": "2006", "volumes": "1758", "first page": "721", "last page": "729", "DOI": "10.1016/j.bbamem.2006.02.012"}, {"title": "Peptide-mediated delivery of therapeutic and imaging agents into mammalian cells", "authors": "Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y", "journal": "Advanced Drug Delivery Reviews", "year": "2001", "volumes": "52", "first page": "153", "last page": "164", "DOI": "10.1016/S0169-409X(01)00197-7"}, {"title": "Nuclear localization signal peptides enhance the delivery of plasmid DNA into the nucleus", "authors": "Zanta MA, Belguise-Valladier P, Behr JP", "journal": "Gene Therapy", "year": "1999", "volumes": "6", "first page": "209", "last page": "217", "DOI": "10.1038/sj.gt.3300817"}, {"title": "Endosomal escape pathways for delivery of biologicals", "authors": "Varkouhi AK, Scholte M, Storm G, Haisma HJ", "journal": "Journal of Controlled Release", "year": "2011", "volumes": "151", "first page": "220", "last page": "228", "DOI": "10.1016/j.jconrel.2010.11.004"}, {"title": "Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges", "authors": "Kang SH, Cho MJ, Kole R", "journal": "Advanced Drug Delivery Reviews", "year": "2008", "volumes": "60", "first page": "1748", "last page": "1757", "DOI": "10.1016/j.addr.2008.08.012"}, {"title": "Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention", "authors": "Sato AK, Viswanathan M, Kent RB, Wood CR", "journal": "Future Medicinal Chemistry", "year": "2006", "volumes": "1", "first page": "1281", "last page": "1291", "DOI": "10.4155/fmc.09.97"}, {"title": "Peptide-mediated delivery of nucleic acids: an overview", "authors": "Ezzat K, El Andaloussi S, Zaghloul EM, Lehto T, Lindberg S, Moreno PM, Viola JR, Magdy T, Abdo R, Guterstam P, Sillard R, Hammond SM, Wood MJ, Arzumanov AA, Gait MJ, Smith CI, Hallbrink M, Langel U", "journal": "Pharmaceuticals", "year": "2011", "volumes": "4", "first page": "385", "last page": "403", "DOI": "10.3390/ph4030385"}, {"title": "Peptide-based vectors for gene delivery", "authors": "Morris MC, Deshayes S, Heitz F, Divita G", "journal": "Chemistry & Biodiversity", "year": "2004", "volumes": "1", "first page": "1301", "last page": "1317", "DOI": "10.1002/cbdv.200490093"}, {"title": "Enhancing the stability and bioavailability of peptide drugs", "authors": "Werle M, Bernkop-Schnurch A", "journal": "Journal of Drug Targeting", "year": "2006", "volumes": "14", "first page": "489", "last page": "496", "DOI": "10.1080/10611860600833892"}, {"title": "Peptide-based drug delivery systems: opportunities and challenges", "authors": "Craik DJ, Fairlie DP, Liras S, Price D", "journal": "Chemical Biology & Drug Design", "year": "2013", "volumes": "81", "first page": "136", "last page": "147", "DOI": "10.1111/cbdd.12055"}]}